Neuromodulation designed to help ventilated patients return to independent breathing

Stimdia is developing innovative technology designed to help patients regain independent breathing and accelerate recovery from mechanical ventilation (MV). hospital costs and in many cases, patient lives.

Our Mission

Stimdia seeks to get patients back to independent breathing to improve outcomes and reduce the economic burden on the healthcare system.

Mechanical ventilation: Lifesaving but costly

In the U.S., roughly one million adult ICU patients require mechanical ventilation each year.^1,2 While MV provides lifesaving respiratory support, weaning patients from a mechanical ventilator is very costly to patients, hospitals, and the healthcare system. It can extend ICU stays, prolong recovery, and increase complications. Reducing the associated risks and costs can both improve patient care and be a major market opportunity.

References

1. Kempker JA, Abril MK, Chen Y, Kramer MR, Waller LA, Martin GS. The Epidemiology of Respiratory Failure in the United States 2002 2017: A Serial Cross-Sectional Study. Crit Care Explor. 2020;2(6):e0128. doi:10.1097/CCE.0000000000000128

2. Carson SS, Cox CE, Holmes GM, Howard A, Carey TS. The changing epidemiology of mechanical ventilation: a population-based study. J Intensive Care Med. 2006;21(3):173-182. doi:10.1177/0885066605282784

3. Pham T, Heunks L, Bellani G, et al. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study. Lancet Respir Med. 2023;11(5):465-476. doi:10.1016/S2213-2600(22)00449-0